Patent Grant
12179182
The present disclosure relates to a method for making a functional structural body having a skeletal body of a porous structure and metallic nanoparticles.
Petrochemical raw materials called naphtha and various fuels such as heavy oil, light oil, kerosene, gasoline, and LP gas are produced from crude oil in petroleum complexes in oil manufacturers. Since the crude oil is a mixture in which various impurities are mixed in addition to the petrochemical raw materials and the various fuels described above, a step of distilling and separating the components contained in the crude oil is required.
Therefore, in the petroleum refining process, the difference in boiling point of each component is used, and crude oil is heated at a shelf stage in a column in an atmospheric pressure distillation apparatus to separate the crude oil into the components, and then the separated substances are concentrated. As a result, a low-boiling point substance such as LP gas or naphtha is removed at the upper shelf stage of the atmospheric pressure distillation apparatus while a high-boiling point substance such as heavy oil is removed from the bottom of the atmospheric pressure distillation apparatus. Then, the separated and concentrated substances are subjected to secondary processing such as desulfurization to produce various fuel products.
In general, refining catalysts have been used to efficiently modify low boiling point naphtha and the like in the above petroleum refining process to produce gasoline having a high octane number and the like. Since the naphtha fraction in the crude oil has a low octane number as it is, and is not suitable as the gasoline for vehicle operation, by modifying the paraffins and naphthenes having a low octane number in the naphtha fraction to an aromatic fractions having a high octane number using refining catalysts, reformed gasoline having characteristics suitable for vehicle fuel is produced.
In addition, as crude oil becomes heavier, hydrocracking treatment is performed in which heavy oil is hydrodesulfurized using a hydrodesulfurization apparatus such as a direct desulfurization apparatus, an indirect desulfurization apparatus, and the like to obtain desulfurized heavy oil, desulfurized heavy gas oil, and the like that are further decomposed to increase production of desulfurized naphtha, desulfurized kerosene, desulfurized light oil, and the like. For example, by hydrocracking the atmospheric pressure distilled residual oil, the yields of the desulfurized light gas distillate and the desulfurized naphtha fraction are increased and the desulfurized heavy oil is decreased, and the LPG fraction, FCC gasoline fraction, and LCO fraction are produced from the desulfurized heavy oil in the catalytic cracking device, and thereby the residual oil is decreased and the distillate of light oil is increased. In this case, a catalyst including a crystalline aluminosilicate support, which is an exemplary zeolite, and a hydrocracking catalyst containing specific proportions of zeolite and a porous inorganic oxide have been proposed.
For example, a catalyst is disclosed in which a metal made from a material selected from Pd, Pt, Co, Fe, Cr, Mo, W and mixtures thereof is deposited on the surface of a support including Y type zeolite as a hydrocracking catalyst (US 2016/0030934).
Furthermore, in the automotive field, as a catalyst structural body for exhaust emissions of automotive equipped with a diesel engine, a ceramic catalyst body is proposed in which a ceramic support is disposed on a ceramic surface of a substrate, and both a main catalyst component and a co-catalyst component are supported on the ceramic support. In this ceramic catalyst body, a large number of pores formed from lattice defects and the like in the crystal lattice are formed in the surface of a ceramic support made of γ-alumina, and a main catalyst component including Ce—Zr, Pt, and the like is directly supported near the surface of the ceramic support (US 2003/0109383).
However, in the catalyst structural body described above, because the catalyst particles are supported on or near the surfaces of the supports, the catalyst particles move within the supports due to the effects of the force, heat, and the like of fluid such as a material to be modified during the modification process, and the aggregation of the catalyst particles (sintering) easily occurs. When aggregation of catalyst particles occurs, the catalytic activity decreases due to the reduction in effective surface area as a catalyst, and therefore the life time of the catalyst becomes shorter than normal. Therefore, the catalyst structural body itself must be replaced or regenerated over a short period of time, which leads to the problem that the replacement operation is cumbersome and resource saving cannot be achieved. Furthermore, since refining catalysts are typically connected to the downstream side of the atmospheric pressure distillation apparatus and are used continuously in a petroleum refining process, it is difficult to apply the catalyst reactivation technique, and even if the reactivation technique can be applied, the work is very complicated.
The present disclosure is related to providing a method for making a functional structural body that can realize a long life time by suppressing the decline in function and that can fulfill resource saving without requiring a complicated replacement operation.
The present inventors have found and completed the disclosure based on such a finding that the functional structural body that can suppress the decline in function of metallic nanoparticles and that can realize a long life time is obtained by including: a skeletal body of a porous structure composed of a zeolite-type compound and at least one type of metallic nanoparticles present in the skeletal body, wherein the skeletal body has channels connecting with each other, and the metallic nanoparticles are held on at least in the channels of the skeletal body.
Namely, the main configurations of the present disclosure are as follows.
{1} A method for making a functional structural body, including:
{2} The method for making a functional structural body according to {1}, wherein 50 to 500 mass % of a non-ionic surfactant is added to the precursor material (A) prior to the calcination step.
{3} The method for making a functional structural body according to [1] or {2}, wherein the precursor material (A) is impregnated with the metal containing solution by adding the metal containing solution to the precursor material (A) in multiple portions prior to the calcination step.
{4} The method for making a functional structural body according to any one of {1} to {3}, wherein in impregnating the precursor material (A) with the metal containing solution prior to the calcination step, the amount of the metal containing solution added to the precursor material (A) is adjusted to 10 to 1000 in terms of the ratio of silicon (Si) constituting the precursor material (A) to the metal element (M) included in the metal containing solution added to the precursor material (A) (ratio of number of atoms Si/M).
{5} The method for making a functional structural body according to {1}, wherein in the hydrothermal treatment step, the precursor material (C) and a structure directing agent are mixed.
{6} The method for making a functional structural body according to {1}, wherein the hydrothermal treatment step is performed in a basic condition.
The present disclosure provides a method for making a functional structural body that can realize a long life time by suppressing the decline in function and that can fulfill resource saving without requiring a complicated replacement operation.
Hereinafter, embodiments of the present disclosure will be described in detail with reference to drawings.
[Configuration of Functional Structural Body]
As shown in
This metallic nanoparticle 20 is a substance that exhibits one or more functions by itself, or in cooperation with the skeletal body 10. Specific examples of the function described above include catalytic function, light emission (or fluorescent) function, light-absorbing function, and identification function. The metallic nanoparticles 20 are preferably, for example, a catalytic substance having a catalytic function. When the metallic nanoparticles 20 are a catalytic substance, the skeletal body 10 is a support that supports the catalytic substance.
In the functional structural body 1, a plurality of types of metallic nanoparticles 20, 20, . . . are embedded in the porous structure of the skeletal body 10. The catalytic substance as an example of the metallic nanoparticles 20 is preferably metallic nanoparticles. The metallic nanoparticles are described in detail below. Furthermore, the metallic nanoparticles 20 may be particles including a metal oxide, a metal alloy, or their composites.
The skeletal body 10 is a porous structure, and as illustrated in
With such a configuration, movement of the metallic nanoparticles 20 within the skeletal body 10 is restricted, and aggregation between the metallic nanoparticles 20 and 20 is effectively prevented. As a result, the decrease in effective surface area of the metallic nanoparticles 20 can be effectively suppressed, and the function of the metallic nanoparticles 20 lasts for a long period of time. In other words, according to the functional structural body 1, the decline in function due to aggregation of the metallic nanoparticles 20 can be suppressed, and the long life time of the functional structural body 1 can be extended. In addition, due to the long life time of the functional structural body 1, the replacement frequency of the functional structural body 1 can be reduced, and the amount of waste of the used functional structural body 1 can be significantly reduced, and thereby can save resources.
Typically, when the functional structural body is used in a fluid (e.g., a heavy oil, or reformed gas such as NOx, etc.), it can be subjected to external forces from the fluid. In this case, if the metallic nanoparticles are only held in an attached state to the outer surface of the skeletal body 10, there is a problem in that they are easy to detach from the outer surface of the skeletal body 10 due to the effect of external force from the fluid. In contrast, in the functional structural body 1, the metallic nanoparticles 20 are held at least in the channels 11 of the skeletal body 10, and therefore, even if subjected to an external force caused by the fluid, the metallic nanoparticles 20 are less likely to detach from the skeletal body 10. That is, when the functional structural body 1 is in the fluid, the fluid flows into the channel 11 from the pore 11a of the skeletal body 10, so that the speed of the fluid flowing through the channel 11 is slower than the speed of the fluid flowing on the outer surface of the skeletal body 10 due to the flow path resistance (frictional force). Due to the effect of such flow path resistance, the pressure received by the metallic nanoparticles 20 held in the channel 11 from the fluid is lower than the pressure received by the metallic nanoparticles from the fluid outside of the skeletal body 10. As a result, detachment of the metallic nanoparticles 20 present in the skeletal body 11 can be effectively suppressed, and the function of the metallic nanoparticles 20 can be stably maintained over a long period of time. Note that the flow path resistance as described above is thought to be larger as the channel 11 of the skeletal body 10 has a plurality of bends and branches, and the interior of the skeletal body 10 becomes a more complex three-dimensional structure.
Preferably, the channel 11 has any one of a one-dimensional pore, a two-dimensional pore, and a three-dimensional pore defined by the framework of a zeolite-type compound and an enlarged pore portion 12 which has a diameter different from any one of the one-dimensional pore, the two-dimensional pore, and the three-dimensional pore. In this case, the metallic nanoparticles 20 are preferably present at least in the enlarged pore portion 12. More preferably, the metallic nanoparticles 20 are embedded at least in the enlarged pore portion 12. Here, the “one-dimensional pore” refers to a tunnel-shaped or cage-shaped pore forming a one-dimensional channel, or a plurality of tunnel-shaped or cage-shaped pores (a plurality of one-dimensional channels) forming a plurality of one-dimensional channels. Also, the “two-dimensional pore” refers to a two-dimensional channel in which a plurality of one-dimensional channels are connected two-dimensionally. The “three-dimensional pore” refers to a three-dimensional channel in which a plurality of one-dimensional channels are connected three-dimensionally.
As a result, movement of the metallic nanoparticles 20 within the skeletal body 10 is further restricted, whereby detachment of the metallic nanoparticles 20 and aggregation between the metallic nanoparticles 20, 20 are effectively prevented. The term “embedding” refers to a state in which the metallic nanoparticles 20 are capsuled inside the skeletal body 10. At this time, the metallic nanoparticles 20 and the skeletal body 10 need not necessarily be in direct contact with each other, but the metallic nanoparticles 20 may be indirectly held by the skeletal body 10 with other substances (e.g., a surfactant, etc.) interposed between the metallic nanoparticles 20 and the skeletal body 10.
Although
Additionally, the enlarged pore portion 12 preferably connects with the plurality of pores 11a, 11a constituting any one of the one-dimensional pore, the two-dimensional pore, and the three-dimensional pore. As a result, a separate channel different from the one-dimensional pore, the two-dimensional pore, or the three-dimensional pore is provided in the interior of the skeletal body 10, so that the function of the metallic nanoparticles 20 can be further exhibited.
Additionally, the channel 11 is formed three-dimensionally by including a branch portion or a merging portion in the interior of the skeletal body 10, and the enlarged pore portion 12 is preferably provided in the branch portion or the merging portion of the channel 11.
The average inner diameter DF of the channel 11 formed in the skeletal body 10 is calculated from the average value of the short diameter and the long diameter of the pore 11a constituting any one of the one-dimensional pore, the two-dimensional pore, and the three-dimensional pore. For example, it is from 0.1 nm to 1.5 nm, and preferably from 0.5 nm to 0.8 nm. The inner diameter DE of the enlarged pore portion 12 is for example from 0.5 nm to 50 nm, preferably from 1.1 nm to 40 nm, and more preferably from 1.1 nm to 3.3 nm. For example, the inner diameter DE of the enlarged pore portion 12 depends on the pore diameter of the precursor material (A) described below and the average particle size DC of the metallic nanoparticles 20 to be embedded. The inner diameter DE of the enlarged pore portion 12 is sized so that the enlarged pore portion 12 is able to embed the metallic nanoparticles 20.
The skeletal body 10 is composed of a zeolite-type compound. Examples of zeolite-type compounds include zeolite analog compounds such as zeolites (alminosilicate salts), cation exchanged zeolites, silicate compounds such as silicalite, alminoborate salts, alminoarsenate salts, and germanate salts; and phosphate-based zeolite analog materials such as molybdenum phosphate. Among these, the zeolite-type compound is preferably a silicate compound.
The framework of the zeolite-type compound is selected from FAU type (Y type or X type), MTW type, MFI type (ZSM-5), FER type (ferrierite), LTA type (A type), MWW type (MCM-22), MOR type (mordenite), LTL type (L type), and BEA type (beta type). Preferably, it is MFI type, and more preferably ZSM-5. A plurality of pores having a pore diameter corresponding to each framework are formed in the zeolite-type compound. For example, the maximum pore diameter of MFI type is 0.636 nm (6.36 Å) and the average pore diameter is 0.560 nm (5.60 Å).
Hereinafter, a case in which the metallic nanoparticles 20 are metallic nanoparticles will be described in detail.
The metallic nanoparticles 20 may be primary particles or secondary particles formed by aggregation of primary particles, but the average particle size DC of the metallic nanoparticles 20 is preferably larger than the average inner diameter DF of the channel 11 and not greater than the inner diameter DE of the enlarged pore portion 12 (DF<DC≤DE). Such metallic nanoparticles 20 are suitably embedded in the enlarged pore portion 12 within the channel 11, and the movement of the nanoparticles 20 within the skeletal body 10 is restricted. Thus, even if the metallic nanoparticles 20 are subjected to an external force from the fluid, movement of the metallic nanoparticles 20 within the skeletal body 10 is suppressed, thereby effectively preventing contact and aggregation between the metallic nanoparticles 20, 20, . . . embedded in the enlarged pore portions 12, 12, . . . dispersed in the channel 11 of the skeletal body 10.
In addition, whether the metallic nanoparticles 20 are primary or secondary particles, the average particle size DC of the metallic nanoparticles 20 is preferably from 0.08 nm to 30 nm, more preferably 0.08 nm or higher and less than 25 nm, and further preferably from 0.4 nm to 11.0 nm, and particularly preferably from 0.8 nm to 2.7 nm. Furthermore, the ratio (DC/DF) of the average particle size DC of the metallic nanoparticles 20 to the average inner diameter DF of the channel 11 is preferably from 0.05 to 300, more preferably from 0.1 to 30, even more preferably from 1.1 to 30, and particularly preferably from 1.4 to 3.6.
When the functional substance 20 is a metallic nanoparticle, the metal element (M) of the metallic nanoparticles is preferably contained in 0.5 to 2.5 mass % relative to the functional structural body 1, and more preferably from 0.5 to 1.5 mass % relative to the functional structural body 1. For example, when the metal element (M) is Co, the content of Co element (mass %) is expressed as {(mass of Co element)/(mass of all elements of the functional structural body 1)}×100.
The metallic nanoparticles only need to be constituted by a metal that is not oxidized, and may be constituted by a single metal or a mixture of two or more types of metals, for example. Note that in the present specification, the “metal” constituting the metallic nanoparticles (as the raw material) refers to an elemental metal containing one type of metal element (M) and a metal alloy containing two or more types of metal elements (M), and the term is a generic term for a metal containing one or more metal elements (M).
Examples of such a metal include platinum (Pt), palladium (Pd), ruthenium (Ru), nickel (Ni), cobalt (Co), molybdenum (Mo), tungsten (W), iron (Fe), chromium (Cr), cerium (Ce), copper (Cu), magnesium (Mg), and aluminum (Al). Preferably, any one of metals described above is the major component.
Furthermore, the ratio of silicon (Si) constituting the skeletal body 10 to the metal element (M) constituting the metallic nanoparticles 20 (the ratio of number of atoms Si/M) is preferably from 10 to 1000, and more preferably from 50 to 200. If the ratio is greater than 1000, the metallic nanoparticles may have a low activity for example, and the effect thereof may not be sufficiently obtained. On the other hand, if the ratio is smaller than 10, the proportion of the metallic nanoparticles 20 becomes too large, and the strength of the skeletal body 10 tends to decrease. Note that the metallic nanoparticles 20 described here, which are present in the interior of the skeletal body 10 or are supported, do not include metallic nanoparticles adhered to the outer surface of the skeletal body 10.
[Function of Functional Structural Body]
The functional structural body 1 includes the skeletal body 10 of a porous structure and at least one type of metallic nanoparticles 20 present in the skeletal body, as described above. The functional structural body 1 exhibits a function depending on the function of the metallic nanoparticles 20 upon contact of the metallic nanoparticles 20 present in the skeletal body with a fluid. In particular, the fluid in contact with the outer surface 10a of the functional structural body 1 flows into the skeletal body 10 through the pore 11a formed in the outer surface 10a and guided into the channel 11, moves through the channel 11, and exits to the exterior of the functional structural body 1 through the other pore 11a. In the pathway through which the fluid travels through the channel 11, contacting with the metallic nanoparticles 20 held in the channel 11 results in a reaction (e.g., a catalytic reaction) depending on the function of the metallic nanoparticles 20. In addition, the functional structural body 1 has molecule sieving capability due to a porous structure of the skeletal body.
The functional structural body 1 has a molecule sieving capability that screens intended molecules contained in a heavy oil such as a residue oil. Specifically, as shown in
In addition, through the above-described reaction, of the molecules generated in the pore 11a by the reaction described above, only the molecules that can exit from the pore 11a to the outside of the skeletal body 10 are obtained as a product, and the molecules that cannot exit from the pore 11a to the outside of the skeletal body 10 are converted to molecules having such a size that they can exit from the pore 11a, and then exit from the pore 11a to the outside of the skeletal body 10. As a result, the product obtained by the catalytic reaction can be limited to intended molecules.
In the functional structural body 1, the metallic nanoparticles 20 are suitably embedded in the enlarged pore portion 12 of the channel 11. Thus, the molecules that have entered into the pore 11a, or the channel 11 come into contact with the metallic nanoparticles 20. When the primary average particle size DC of the metallic nanoparticles 20 is larger than the average inner diameter DF of the channel 11 and smaller than the inner diameter DE of the enlarged pore portion 12 (DF<DC<DE), a small channel 13 is formed between the metallic nanoparticles 20 and the enlarged pore portion 12 (
When the molecules that have entered into the channel 11 come into contact with the metallic nanoparticles 20, the molecules (substance to be modified) are modified by the oxidative decomposition reaction of the metallic nanoparticles 20. For example, when ruthenium contained in the metallic nanoparticles 20 is used as a catalyst, ammonia is oxidatively decomposed to generate nitrogen and hydrogen. By performing the oxidative decomposition treatment using a metal catalyst in this manner, the hydrogen used in the hydrocracking process in the related art becomes unnecessary, and heavy components, which have not been sufficiently utilized in terms of local limitations and costs of hydrogen supply, can be modified into light oils. The substance to be treated is not limited to the intended molecules contained in a heavy oil, and may be intended molecules contained in other raw oils such as naphtha, kerosene, and light oil.
Because the metallic nanoparticles 20 are a non-oxidized metal, when the fluid is at a high temperature, the metallic nanoparticles 20 can diffuse due to heat received from the fluid and finely divided by diffusion, and can be detached from the enlarged pore portion 12. However, the phenomenon in which small metallic nanoparticles having a small particle size of approximately 5 nm diffuse in the form of smaller metallic nanoparticles is unstable, and high activation energy is required for the progress of the diffusion, thus the above-described diffusion is difficult to proceed. In addition, even if diffusion has progressed, the metallic nanoparticles 20 become finely divided, thus the effective surface area as a catalyst after diffusion increases compared to before diffusion. In addition, although the channel 11 is described in a simplified form in
[Method for Making Functional Structural Body]
(Step S1: Preparation Step)
As shown in
Here, when the zeolite-type compound constituting the skeletal body of the functional structural body is a silicate compound, the regular mesopore material is preferably a compound including a Si—O skeleton in which pores having a pore diameter of 1 to 50 nm are uniformly sized and regularly developed one-dimensionally, two-dimension-ally, or three-dimensionally. While such a regular mesopore material is obtained as a variety of synthetic materials depending on the synthetic conditions. Specific examples of the synthetic material include SBA-1, SBA-15, SBA-16, KIT-6, FSM-16, and MCM-41. Among them, MCM-41 is preferred. Note that the pore diameter of SBA-1 is from 10 to 30 nm, the pore diameter of SBA-15 is from 6 to 10 nm, the pore diameter of SBA-16 is 6 nm, the pore diameter of KIT-6 is 9 nm, the pore diameter of FSM-16 is from 3 to 5 nm, and the pore diameter of MCM-41 is from 1 to 10 nm. Examples of such a regular mesopore material include mesoporous silica, mesoporous aluminosilicate, and mesoporous metallosilicate.
The precursor material (A) may be a commercially available product or a synthetic product. When the precursor material (A) is synthesized, it can be synthesized by a known method for synthesizing a regular mesopore material. For example, a mixed solution including a raw material containing the constituent elements of the precursor material (A) and a molding agent for defining the structure of the precursor material (A) is prepared, and the pH is adjusted as necessary to perform hydrothermal treatment (hydrothermal synthesis). Thereafter, the precipitate (product) obtained by hydrothermal treatment is collected (e.g., filtered), washed and dried as necessary, and then calcinated to obtain a precursor material (A) which is a powdered regular mesopore material. Here, examples of the solvent of the mixed solution that can be used include water, an organic solvent such as alcohol, or a mixed solvent thereof. In addition, the raw material is selected according to the type of the skeletal body, but examples thereof include silica agents such as tetraethoxysilane (TEOS), fumed silica, and quartz sand. In addition, various types of surfactants, block copolymers, and the like can be used as the molding agent, and it is preferably selected depending on the type of the synthetic materials of the regular mesopore material. For example, a surfactant such as hexadecyltrimethylammonium bromide is preferable for producing MCM-41. The hydrothermal treatment can be performed at 0 to 2,000 kPa at 80 to 800° C. for 5 hours to 240 hours in a sealed container. For example, the calcination treatment can be performed in air, at 350 to 850° C. for 2 hours to 30 hours.
(Step S2: Impregnating Step)
The prepared precursor material (A) is then impregnated with the metal containing solution to obtain the precursor material (B).
The metal containing solution is a solution containing a metal component (for example, a metal ion) corresponding to the metal element (M) constituting the metallic nanoparticles of the functional structural body, and can be prepared, for example, by dissolving a metal salt containing the metal element (M) in a solvent. Examples of such metal salts include metal salts such as chlorides, hydroxides, oxides, sulfates, and nitrates. Of these, nitrates are preferable. Examples of the solvent that can be used include water, an organic solvent such as alcohol, or a mixed solvent thereof.
The method for impregnating the precursor material (A) with the metal containing solution is not particularly limited; however, for example, the metal containing solution is preferably added in portions several times under stirring the powdered precursor material (A) before the calcination step described below. In addition, the surfactant is preferably added to the precursor material (A) as an additive to the precursor material (A) before adding the metal containing solution, from the perspective of allowing the metal containing solution to enter the pores of the precursor material (A) more easily. It is believed that such additives serve to cover the outer surface of the precursor material (A) and inhibit the subsequently added metal containing solution from adhering to the outer surface of the precursor material (A), making it easier for the metal containing solution to enter the pores of the precursor material (A).
Examples of such additives include non-ionic surfactants such as polyoxyethylene oleyl ether, polyoxyethylene alkyl ether, and polyoxyethylene alkylphenyl ether. It is believed that these surfactants do not adhere to the interior of the pores because their molecular size is large and cannot enter the pores of the precursor material (A), and will not interfere with the penetration of the metal containing solution into the pores. As the method for adding the non-ionic surfactant, for example, it is preferable to add from 50 to 500 mass % of the non-ionic surfactant relative to the precursor material (A) prior to the calcination step described below. If the added amount of the non-ionic surfactant is less than 50 mass % relative to the precursor material (A), the aforementioned suppressing effect is not easily exhibited, and when more than 500 mass % of the non-ionic surfactant relative to the precursor material (A) is added, the viscosity is too high, which is not preferable. Thus, the added amount of the non-ionic surfactant relative to the precursor material (A) is a value within the range described above.
Furthermore, the added amount of the metal containing solution added to the precursor material (A) is preferably adjusted as appropriate in consideration of the amount of the metal element (M) contained in the metal containing solution with which the precursor material (A) is impregnated (that is, the amount of the metal element (M) present in the precursor material (B)). For example, prior to the calcination step described below, the added amount of the metal containing solution added to the precursor material (A), in terms of a ratio of silicon (Si) constituting the precursor material (A) to a metal element (M) included in the metal containing solution added to the precursor material (A) (the ratio of number of atoms Si/M), is preferably adjusted to 10 to 1000, and more preferably 50 to 200. For example, if a surfactant as an additive is added to the precursor material (A) prior to adding the metal containing solution to the precursor material (A), the content of the metal element (M) of the metallic nanoparticles in the functional structural body 1 can be adjusted to 0.5 to 2.5 mass % by adding the metal containing solution to the precursor material (A) in an amount of 50 to 200 in terms of the ratio of number of atoms Si/M. In the state of the precursor material (B), the amount of the metal element (M) present within the pores is generally proportional to the added amount of the metal containing solution added to the precursor material (A) if the metal concentration of the metal containing solution, the presence or absence of additives, and other conditions such as temperature, pressure, and the like are the same. Additionally, the amount of the metal element (M) present in the precursor material (B) is in a proportional relation to the amount of the metal element constituting the metallic nanoparticles present in the skeletal body of the functional structural body. Thus, by controlling the amount of the metal containing solution added to the precursor material (A) to the range described above, the pores of the precursor material (A) can be sufficiently impregnated with the metal containing solution, and thus the amount of the metallic nanoparticles present in the skeletal body of the functional structural body can be adjusted.
After impregnating the precursor material (A) with the metal containing solution, a washing treatment may be performed as necessary. Examples of the washing solution that can be used include water, an organic solvent such as alcohol, or a mixed solvent thereof. Furthermore, the precursor material (A) is preferably impregnated with the metal containing solution, and after the washing treatment is performed as necessary, the precursor material (A) is further subjected to drying treatment. Drying treatments include overnight natural drying and high temperature drying at 150° C. or lower. Note that when calcination treatment described below is performed in the state in which a large amount of moisture contained in the metal containing solution and the wash solution remains in the precursor material (A), the skeletal structure as the regular mesopore material of the precursor material (A) may be broken, and thus it is preferable to dry them sufficiently.
(Step S3: Calcination Step)
Next, a precursor material (C) is obtained by calcinating the precursor material (B) obtained by impregnating the precursor material (A) for obtaining the skeletal body of the porous structure composed of a zeolite-type compound with the metal containing solution.
For example, the calcination treatment is preferably performed in air, at 350 to 850° C. for 2 hours to 30 hours. Through this calcination treatment, the metal component that has entered into the pores of the regular mesopore material undergoes crystal growth, and metallic nanoparticles are formed in the pores.
(Step S4: Hydrothermal Treatment Step)
A mixed solution of the precursor material (C) and a structure directing agent is then prepared, and the precursor material (C) obtained by calcinating the precursor material (B) is hydrothermally treated to obtain a functional structural body.
The structure directing agent is a molding agent for defining the framework of the skeletal body of the functional structural body, for example the surfactant can be used. The structure directing agent is preferably selected according to the framework of the skeletal body of the functional structural body, and for example, a surfactant such as tetramethylammonium bromide (TMABr), tetraethylammonium bromide (TEABr), and tetrapropylammonium bromide (TPABr) are suitable.
The mixing of the precursor material (C) and the structure directing agent may be performed during the hydrothermal treatment step or may be performed before the hydrothermal treatment step. Furthermore, the method for preparing the mixed solution is not particularly limited, and the precursor material (C), the structure directing agent, and the solvent may be mixed simultaneously, or the respective dispersion solutions may be mixed after the precursor material (C) and the structure directing agent are each dispersed in the solvent to form a solution. Examples of the solvent that can be used include water, an organic solvent such as alcohol, or a mixed solvent thereof. In addition, it is preferable that the pH of the mixed solution is adjusted using an acid or a base prior to performing the hydrothermal treatment.
The hydrothermal treatment can be performed by a known method. For example, the hydrothermal treatment can be preferably performed at 0 to 2,000 kPa at 80 to 800° C. for 5 hours to 240 hours in a sealed container. Furthermore, the hydrothermal treatment is preferably performed under a basic condition.
Although the reaction mechanism here is not necessarily clear, by performing hydrothermal treatment using the precursor material (C) as a raw material, the skeletal structure as the regular mesopore material of the precursor material (C) becomes gradually disrupted. However, under the action of the structure directing agent, a new framework (porous structure) is formed as the skeletal body of the functional structural body while substantially maintaining the position of the metallic nanoparticles within the pores of the precursor material (C). The functional structural body obtained in this way includes the skeletal body having the porous structure and metallic nanoparticles present in the skeletal body, and the skeletal body has a channel in which a plurality of pores connect with each other by the porous structure, and at least a portion of the metallic nanoparticles are present in the channel of the skeletal body.
Furthermore, in the present embodiment, in the hydrothermal treatment step, a mixed solution in which the precursor material (C) and the structure directing agent are mixed is prepared, and the precursor material (C) is subjected to hydrothermal treatment, which is not a limitation. The precursor material (C) may be subjected to hydrothermal treatment without mixing the precursor material (C) and the structure directing agent.
The precipitate obtained after hydrothermal treatment (functional structural body) is preferably washed, dried, and calcinated as necessary after being collected (e.g., filtered). Examples of the washing solution that can be used include water, an organic solvent such as alcohol, or a mixed solution thereof. Drying treatments include overnight natural drying and high temperature drying at 150° C. or lower. Note that when calcination treatment is performed in the state in which there is a large amount of moisture remaining in the precipitate, the framework as a skeletal body of the functional structural body may be broken, and thus it is preferable to dry the precipitate sufficiently. For example, the calcination treatment can be performed in air, at 350 to 850° C. for 2 hours to 30 hours. Such calcination treatment burns out the structure directing agent that has been attached to the functional structural body. Furthermore, the functional structural body can be used as is without subjecting the collected precipitate to calcination treatment, depending on the intended use. For example, if the environment in which the functional structural body is used is a high temperature environment of an oxidizing atmosphere, exposing the functional structural body to a usage environment for a period of time allows the structure directing agent to be burned out and to obtain a functional structural body similar to that when subjected to calcination treatment. Thus, the obtained functional structural body can be used as is.
The making method described above is an example in which the metal element (M) contained in the metal containing solution that impregnates the precursor material (A) is a metal species (e.g., a noble metal) that is hard to be oxidized.
When the metal element (M) contained in the metal containing solution that impregnates the precursor material (A) is an easily oxidized metal species (e.g., Fe, Co, or Cu), the hydrothermally treated precursor material (C) after the hydrothermal treatment step is preferably subjected to reduction treatment. When the metal element (M) contained in the metal containing solution is an easily oxidized metal species, the metal component can be oxidized by the heat treatment in the steps (steps S3 to S4) after the impregnating treatment (step S2). Therefore, metal oxide nanoparticles are present in the skeletal body formed in the hydrothermal treatment step (step S4). Therefore, in order to obtain a functional structural body in which metallic nanoparticles are present in its skeletal body, it is preferred that the collected precipitate be calcinated after the hydrothermal treatment, and further subjected to reduction treatment in a reducing gas atmosphere such as hydrogen gas (step S5: reduction treatment step). Through the reduction treatment, the metallic nanoparticles present in the skeletal body are reduced to form metallic nanoparticles that correspond to the metal element (M) constituting the metal oxide nanoparticles. As a result, a functional structural body in which metallic nanoparticles are present in its skeletal body is obtained. The reduction treatment may be performed as necessary. For example, if the environment in which the functional structural body is used is a reducing atmosphere, the metallic nanoparticles are reduced by exposing the functional structural body to a usage environment for a period of time, so that a functional structural body similar to that obtained when subjected to reduction treatment is obtained. Thus, the obtained functional structural body can be used as is in the form including oxide nanoparticles in the skeletal body.
[Modified Example of Functional Structural Body 1]
Although the functional structural body 1 of
This metallic nanoparticles 30 is a substance that exhibits one or more functions. The function of the metallic nanoparticles 30 may be the same as or different from the function of the metallic nanoparticles 20. A specific example of the function of the metallic nanoparticles 30 is the same as that described for the metallic nanoparticles 20, and preferably has a catalytic function, and in this case the metallic nanoparticles 30 are a catalytic substance. Also, if both of the metallic nanoparticles 20 and 30 are materials having the same function, the material of the other metallic nanoparticles 30 may be the same as or different from the material of the metallic nanoparticles 20. According to this configuration, the content of the metallic nanoparticles held in the functional structural body 2 can be increased, and the functions of the metallic nanoparticles can be further exhibited.
In this case, the content of the metallic nanoparticles 20 present in the skeletal body 10 is preferably greater than that of the other metallic nanoparticles 30 held on the outer surface 10a of the skeletal body 10. As a result, the function of the metallic nanoparticles 20 held inside the skeletal body 10 becomes dominant, whereby the function of the metallic nanoparticles is stably exhibited.
Hereinbefore, the functional structural body according to the embodiments of the disclosure has been described, but the present disclosure is not limited to the above embodiments, and various modifications and changes are possible on the basis of the technical concept of the present disclosure.
[Synthesis of Precursor Material (A)]
A mixed aqueous solution was prepared by mixing a silica agent (tetraethoxysilane (TEOS), available from Wako Pure Chemical Industries, Ltd.) and a surfactant as a molding agent. The pH was adjusted as appropriate, and hydrothermal treatment was performed at 80 to 350° C. for 100 hours in a sealed container. Thereafter, the produced precipitate was filtered out, washed with water and ethanol, and then calcinated in air at 600° C. for 24 hours to obtain the precursor material (A) having the type and the pore diameter shown in Tables 1 to 8. Note that the following surfactant was used depending on the type of the precursor material (A) (“the type of precursor material (A): surfactant”).
Next, a metal containing aqueous solution was prepared by dissolving a metal salt containing the metal element (M) in water according to the metal element (M) constituting the metallic nanoparticles of the type shown in Tables 1 to 8. Following metal salts were used in accordance with the type of metallic nanoparticles (“metallic nanoparticles: metal salt”).
Next, a metal containing solution was added to the powdered precursor material (A) in portions, and dried at room temperature (20° C.±10° C.) for 12 hours or longer to obtain the precursor material (B).
Note that when the presence or absence of additives shown in Tables 1 to 8 is “yes”, pretreatment in which an aqueous solution of polyoxyethylene (15) oleyl ether (NIKKOL BO-15 V, available from Nikko Chemicals Co., Ltd.) is added as the additive to the precursor material (A) prior to adding the metal containing aqueous solution, and then the aqueous solution containing a metal was added as described above. Note that when “no” is used in the presence or absence of an additive, pretreatment with an additive such as that described above has not been performed.
Furthermore, the added amount of the metal containing aqueous solution added to the precursor material (A) was adjusted such that the value obtained by converting it to a ratio of silicon (Si) constituting the precursor material (A) to a metal element (M) included in the metal containing solution (the ratio of number of atoms of Si/M) is in Tables 1 to 8.
Next, the precursor material (B) impregnated with the metal containing aqueous solution obtained as described above was calcinated in air at 600° C. for 24 hours to obtain the precursor material (C).
The precursor material (C) obtained as described above and the structure directing agent shown in Tables 1 to 8 were mixed to produce a mixed aqueous solution. Hydrothermal treatment was performed under the conditions of at 80 to 350° C., at pH and time shown in Tables 1 to 8 in a sealed container. Thereafter, the produced precipitate was filtered out, washed with water, dried at 100° C. for 12 hours or longer, and then calcinated in air at 600° C. for 24 hours. The calcinated product was then collected and subjected to reduction treatment under purging hydrogen gas at 400° C. for 350 minutes to obtain functional structural bodies containing a skeletal body and metallic nanoparticles shown in Tables 1 to 8 (Examples 1 to 384).
In Comparative Example 1, cobalt oxide powder (II, III) having an average particle size of 50 nm or less (available from Sigma-Aldrich Japan LLC) was mixed with MFI type silicalite, subjected to hydrogen reduction treatment in the similar manner as in Examples, thereby obtaining a functional structural body in which cobalt oxide nanoparticles were attached as the functional substance to the outer surface of the silicalite as the skeletal body. MFI type silicalite was synthesized in the similar manner as in Examples 52 to 57 except for a step of adding a metal.
In Comparative Example 2, MFI type silicalite was synthesized in the similar manner as in Comparative Example 1 except that the step of attaching the cobalt oxide nanoparticles was omitted.
[Evaluation]
Various characteristic evaluations were performed on the functional structural bodies of the above examples and the silicalite of the comparative examples under the conditions described below.
[A] Cross Sectional Observation
The functional structural bodies of the examples and the silicalite of the comparative examples were pulverized to make observation samples, and their cross sections were observed using a transmission electron microscope (TEM) (TITAN G2, available from FEI).
As a result, it was confirmed that, in the functional structural body of the examples described above, metallic nanoparticles were included and held in the skeletal body made of silicalite or zeolite. On the other hand, in the silicalite of Comparative Example 1, the metallic nanoparticles were only attached to the outer surface of the skeletal body and were not present in the skeletal body.
In addition, of the examples described above, the functional structural body including iron nanoparticles (Fe) capsuled therein as the metal was cut out to obtain a cross section by focused ion beam (FIB) processing, and cross-sectional elemental analysis was performed using SEM (SU8020, available from Hitachi High-Technologies Corporation) and EDX (X-Max, available from Horiba, Ltd.). As a result, elements Fe were detected inside the skeletal body.
From the results of the cross-sectional observation using TEM and SEM/EDX, the presence of iron nanoparticles in the skeletal body was confirmed.
[B] Average Inner Diameter of the Channel of the Skeletal Body and Average Particle Size of the Metallic Nanoparticles
In the TEM image taken by the cross-sectional observation performed in evaluation [A] above, 500 channels of the skeletal body were randomly selected, and the respective major diameter and the minor diameter were measured, and the respective inner diameters were calculated from the average values (N=500), and the average value of the inner diameter was designated as the average inner diameter DF of the channel of the skeletal body. In addition, in the same manner for the metallic nanoparticles, 500 metallic nanoparticles were randomly selected from the TEM image, and the respective particle sizes were measured (N=500), and the average value thereof was designated as the average particle size DC of the metallic nanoparticles. The results are shown in Tables 1 to 8.
Also, SAXS (small angle X-ray scattering) was used to analyze the average particle size and dispersion status of the functional substance. Measurements by SAXS were performed using a Spring-8 beam line BL19B2. The obtained SAXS data was fitted with a spherical model using the Guinier approximation method, and the particle size was calculated. The particle size was measured for the functional structural body in which the metal was iron nanoparticles. Furthermore, as a comparative reference, commercially available iron nanoparticles (available from Wako) was observed and measured on SEM.
As a result, in the commercial product, various sizes of iron nanoparticles were randomly present in a range of particle sizes of approximately 50 nm to 400 nm, whereas in the measurement results of SAXS, scattering peaks with particle sizes of 10 nm or less were also detected for the functional structural bodies of Examples having an average particle size of 1.2 nm to 2.0 nm as determined from the TEM image. From the results of SAXS measurement and the SEM/EDX cross-sectional measurement, it was found that functional substances having a particle size of 10 nm or less are present in the skeletal body in a very highly dispersed state with a uniform particle sizes.
[C] Relationship Between the Added Amount of the Metal Containing Solution and the Amount of Metal Embedded in the Skeletal Body
A functional structural body in which metallic nanoparticles were embedded in the skeletal body at an added amount in terms of the ratio of number of atoms of Si/M=50, 100, 200, 1000 (M=Co, Ni, Fe, Cu) was produced, and then the amount of metal (mass %) that was embedded in the skeletal body of the functional structural body made at the above added amount was measured. Note that in the present measurement, a functional structural body with the ratio of number of atoms Si/M=100, 200, 1000 is produced by adjusting the added amount of the metal containing solution in the same manner as the functional structural body of the ratio of number of atoms Si/M=100, 200, 1000 in Examples 1 to 384, and functional structural bodies with the ratio of number of atoms Si/M=50 were made in the same manner as the functional structural body with the ratio of number of atoms Si/M=100, 200, 1000, except that the added amount of the metal containing solution was different.
The amount of metal was quantified by ICP (radiofrequency inductively coupled plasma) alone or in combination with ICP and XRF (fluorescence X-ray analysis). XRF (energy dispersive fluorescent x-ray analyzer “SEA1200VX”, available from SSI Nanotechnology) was performed under conditions of a vacuum atmosphere, an accelerating voltage of 15 kV (using a Cr filter), or an accelerating voltage of 50 kV (using a Pb filter).
XRF is a method for calculating the amount of metal present in terms of fluorescence intensity, and XRF alone cannot calculate a quantitative value (in terms of mass %). Therefore, the metal content of the functional structural body to which the metal was added at Si/M=100 was determined by ICP analysis, and the metal content of the functional structural body in which the metal was added at Si/M=50 and less than 100 was calculated based on XRF measurement results and ICP measurement results.
As a result, it was confirmed that the amount of metal embedded in the functional structural body increases as the added amount of the metal containing solution increases, and was at least within a range that the ratio of numbers of atoms is within 50 to 1000.
[D] Performance Evaluation
The catalytic ability (performance) of the metallic nanoparticles (catalytic substance) was evaluated for the functional structural bodies of the examples described above and the silicalite of the comparative examples. The results are shown in Tables 1 to 8.
(1) Catalytic Activity
The catalytic activity was evaluated under the following conditions:
First, 0.2 g of the functional structural body was charged in a normal pressure flow reactor, and a decomposition reaction of butylbenzene (model material for heavy oil) was performed with nitrogen gas (N2) as a carrier gas (5 ml/min) at 400° C. for 2 hours.
After completion of the reaction, the generated gas and the generated liquid that were collected were analyzed by gas chromatography (GC) and gas chromatography mass spectrometry (GC/MS) for the composition. Note that, as the analysis device, TRACE 1310 GC (available from Thermo Fisher Scientific Inc., detector: thermal conductivity detector, flame ionization detector), and TRACE DSQ (Thermo Fischer Scientific Inc., detector: mass detector, ionization method: EI (ion source temperature 250° C., MS transfer line temperature of 320° C.)) were used.
Furthermore, based on the results of the composition analysis described above, the yield (mol %) of a compound having a molecular weight lower than that of butylbenzene (specifically, benzene, toluene, ethylbenzene, styrene, cumene, methane, ethane, ethylene, propane, propylene, butane, butene, and the like) was determined. The yield of the compound was calculated as the percentage (mol %) of the total amount (mol) of the amount of substance of the compound having a lower molecular weight than the butylbenzene contained in the production liquid (mol %) relative to the amount of substance (mol) of butylbenzene prior to the reaction.
In the present example, when the yield of a compound having a molecular weight lower than that of butylbenzene contained in the product liquid is 40 mol % or more, it is determined that the catalytic activity (capacity of decomposition) is excellent, and considered as “A”. When it is 25 mol % or more and less than 40 mol %, it is determined that the catalytic activity is good, and considered as “B”. When it is 10 mol % or more and less than 25 mol %, it is determined that the catalytic activity is not good, but is pass level (acceptable), and considered as “C”. When it is less than 10 mol %, it is determined that the catalytic activity is poor (not pass), and considered as “D”.
(2) Durability (Life Time)
The durability was evaluated under the following conditions:
First, the functional structural body used in evaluation (1) above was collected and heated at 650° C. for 12 hours to produce a functional structural body after heating. Next, a decomposition reaction of butylbenzene (model material of heavy oil) was performed by the similar method as in evaluation (1) above using the obtained functional structural body after heating, and composition analysis of the generated gas and the generated liquid was performed in the similar manner as in the above evaluation (1).
Based on the obtained analytical results, the yield (mol %) of a compound having a molecular weight lower than that of butylbenzene was determined in the similar manner as in evaluation (1) above. Furthermore, the yield of the above compound by the functional structural body after heating was compared with the yield of the above compound by the functional structural body prior to heating (the yield determined in evaluation (1) above) to determine the degree of maintenance. Specifically, the percentage (%) of the yield of the compound obtained by the functional structural body after heating (yield determined by the present evaluation (2) above) to the yield of the above compound by the functional structural body prior to heating (yield determined by the evaluation (1) above) was calculated.
In the present embodiment, when the yield of the compound (yield determined by the present evaluation (2)) of the above compound obtained by the functional structural body after heating (yield determined by the present evaluation (2)) is maintained at least 80% compared to the yield of the compound obtained by the functional structural body prior to heating (yield determined by evaluation (1) above), it is determined that the durability (heat resistance) is excellent, and considered as “A”. When it is maintained 60% or more and less than 80%, it is determined that the durability (heat resistance) is good, and considered as “B”. When it is maintained 40% or more and less than 60%, it is determined that the durability (heat resistance) is not good, but is pass level (acceptable), and considered as “C”. When it is reduced below 40%, it is determined that the durability (heat resistance) is poor (not pass), and considered as “D”.
Performance evaluations similar to those of evaluation (1) and (2) above were also performed on Comparative Examples 1 and 2. Note that Comparative Example 2 contains the skeletal body only, but do not contain the functional substance. Therefore, in the performance evaluation described above, only the skeletal body of Comparative Example 2 was charged in place of the functional structural body. The results are shown in Table 8.
As can be seen from Tables 1 to 8, the functional structural bodies (Examples 1 to 384), which were confirmed by cross sectional observation to hold the metallic nanoparticles inside the skeletal bodies, were found to exhibit excellent catalytic activity in the decomposition reaction of butylbenzene and excellent durability as a catalyst compared to the functional structural body in which the metallic nanoparticles were simply adhered to the outer surface of the skeletal body (Comparative Example 1) or the skeletal body having no functional substance (Comparative Example 2).
In addition, the relationship between the amount of metal (mass %) embedded in the skeletal body of the functional structural body measured in the evaluation [C] and the yield (mol %) determined in the evaluation (1) was evaluated. The evaluation method was the same as the evaluation method performed in “(1) catalytic activity” in the [D] “performance evaluation” described above.
As a result, in each example, when the amount of the metal containing solution added to the precursor material (A) was from 50 to 200 in terms of the ratio of number of atoms Si/M (the content of the metal element (M) of the metallic nanoparticles relative to the functional structural body was from 0.5 to 2.5 mass %), the yield of the compound having a molecular weight lower than that of butylbenzene contained in the product liquid was 32 mol % or greater, and the catalytic activity in the decomposition reaction of butylbenzene was particularly excellent.
On the other hand, the silicalite of Comparative Example 1, in which the metallic nanoparticles were attached only to the outer surface of the skeletal body, exhibited improved catalytic activity in the decomposition reaction of butylbenzene compared to the skeletal body having no metallic nanoparticle in Comparative Example 2, but exhibited inferior durability as a catalyst compared to the functional structural bodies in Examples 1 to 384.
In addition, the skeletal body having no functional substance in Comparative Example 2 exhibited little catalytic activity in the decomposition reaction of butylbenzene, and was inferior in both the catalytic activity and the durability to the functional structural bodies in Examples 1 to 384.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2017-108584 | May 2017 | JP | national |
This is a divisional application of U.S. patent application Ser. No. 16/698,670 filed on Nov. 27, 2019 and issued as U.S. Pat. No. 11,648,538 on May 16, 2023, which is a continuation application of International Patent Application No. PCT/JP2018/021079 filed May 31, 2018, which claims the benefit of Japanese Patent Application No. 2017-108584 filed May 31, 2017, and the full contents of all of which are hereby incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3898180 | Crooks et al. | Aug 1975 | A |
| 4552855 | Ozin et al. | Nov 1985 | A |
| 5026673 | Gates et al. | Jun 1991 | A |
| 5236575 | Bennett et al. | Aug 1993 | A |
| 5275720 | Ward | Jan 1994 | A |
| 5849652 | Davies et al. | Dec 1998 | A |
| 5994603 | Mohr et al. | Nov 1999 | A |
| 6040259 | Mohr et al. | Mar 2000 | A |
| 6831203 | Mohr et al. | Dec 2004 | B1 |
| 6881703 | Cutler et al. | Apr 2005 | B2 |
| 7074373 | Warren et al. | Jul 2006 | B1 |
| 7592291 | Rollins et al. | Sep 2009 | B2 |
| 7893311 | Takamatsu et al. | Feb 2011 | B2 |
| 11161101 | Kato et al. | Nov 2021 | B2 |
| 11547987 | Masuda et al. | Jan 2023 | B2 |
| 20030109383 | Koike et al. | Jun 2003 | A1 |
| 20030188991 | Shan et al. | Oct 2003 | A1 |
| 20040176245 | Hagemeyer et al. | Sep 2004 | A1 |
| 20040192947 | Chane-Ching et al. | Sep 2004 | A1 |
| 20050201920 | Shan et al. | Sep 2005 | A1 |
| 20060211777 | Severinsky | Sep 2006 | A1 |
| 20060216227 | Idem et al. | Sep 2006 | A1 |
| 20070004593 | Ohno et al. | Jan 2007 | A1 |
| 20070167551 | Goodwin et al. | Jul 2007 | A1 |
| 20080045400 | Rollins et al. | Feb 2008 | A1 |
| 20080045403 | Rollins et al. | Feb 2008 | A1 |
| 20080051280 | Hagemeyer et al. | Feb 2008 | A1 |
| 20080072705 | Chaumonnot et al. | Mar 2008 | A1 |
| 20080280754 | Toledo et al. | Nov 2008 | A1 |
| 20080293990 | Stevenson et al. | Nov 2008 | A1 |
| 20090286677 | Takeshima et al. | Nov 2009 | A1 |
| 20090325790 | Haller et al. | Dec 2009 | A1 |
| 20100004118 | Liu et al. | Jan 2010 | A1 |
| 20110085944 | Rolllins et al. | Apr 2011 | A1 |
| 20110092356 | Rollins et al. | Apr 2011 | A1 |
| 20110092745 | Senoo et al. | Apr 2011 | A1 |
| 20110121238 | Wakatsuki | May 2011 | A1 |
| 20110293941 | Chaumonnot et al. | Dec 2011 | A1 |
| 20120042631 | Schmieg et al. | Feb 2012 | A1 |
| 20120060472 | Li et al. | Mar 2012 | A1 |
| 20120130138 | Yamaguchi et al. | May 2012 | A1 |
| 20120142238 | Saitou et al. | Jun 2012 | A1 |
| 20120231948 | Saito | Sep 2012 | A1 |
| 20130041174 | Yamamoto et al. | Feb 2013 | A1 |
| 20130090445 | Hattori et al. | Apr 2013 | A1 |
| 20130196158 | Yoshida et al. | Aug 2013 | A1 |
| 20140021096 | Chaumonnot et al. | Jan 2014 | A1 |
| 20140128246 | Garcia-Martinez | May 2014 | A1 |
| 20140147362 | Sasaki et al. | May 2014 | A1 |
| 20140284524 | Lee et al. | Sep 2014 | A1 |
| 20140303266 | Hyman | Oct 2014 | A1 |
| 20150018590 | Stevenson et al. | Jan 2015 | A1 |
| 20150290635 | Inokawa et al. | Oct 2015 | A1 |
| 20150367332 | Kuvettu et al. | Dec 2015 | A1 |
| 20160017238 | Stamires et al. | Jan 2016 | A1 |
| 20160023913 | Goel et al. | Jan 2016 | A1 |
| 20160024400 | Iwasa et al. | Jan 2016 | A1 |
| 20160030934 | Zhan et al. | Feb 2016 | A1 |
| 20160032202 | Yonemura et al. | Feb 2016 | A1 |
| 20160087285 | Watanabe et al. | Mar 2016 | A1 |
| 20160114314 | Ali et al. | Apr 2016 | A1 |
| 20160129429 | Kegnæs et al. | May 2016 | A1 |
| 20160137516 | Kegnæs | May 2016 | A1 |
| 20160369174 | Kool et al. | Dec 2016 | A1 |
| 20170036197 | Kegnæs et al. | Feb 2017 | A1 |
| 20180194700 | Pan et al. | Jul 2018 | A1 |
| 20190039056 | Kato et al. | Feb 2019 | A1 |
| 20200094229 | Masuda et al. | Mar 2020 | A1 |
| 20200094232 | Masuda et al. | Mar 2020 | A1 |
| 20200108374 | Masuda et al. | Apr 2020 | A1 |
| 20200108378 | Masuda et al. | Apr 2020 | A1 |
| 20200114335 | Masuda et al. | Apr 2020 | A1 |
| 20200114336 | Masuda et al. | Apr 2020 | A1 |
| 20200114337 | Masuda et al. | Apr 2020 | A1 |
| 20200114338 | Masuda et al. | Apr 2020 | A1 |
| 20200114339 | Masuda et al. | Apr 2020 | A1 |
| 20200114341 | Masuda et al. | Apr 2020 | A1 |
| 20200115248 | Masuda et al. | Apr 2020 | A1 |
| 20200115640 | Masuda et al. | Apr 2020 | A1 |
| 20200254432 | Shirman et al. | Aug 2020 | A1 |
| 20230009052 | Masuda et al. | Jan 2023 | A1 |
| 20230201814 | Masuda et al. | Jun 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 2256515 | Dec 1997 | CA |
| 1223602 | Jul 1999 | CN |
| 1720098 | Jan 2006 | CN |
| 1729138 | Feb 2006 | CN |
| 1876766 | Dec 2006 | CN |
| 101130466 | Feb 2008 | CN |
| 101180125 | May 2008 | CN |
| 101362959 | Feb 2009 | CN |
| 101720252 | Jun 2010 | CN |
| 101909750 | Dec 2010 | CN |
| 105377424 | Mar 2016 | CN |
| 0485180 | May 1992 | EP |
| 1709125 | Oct 2006 | EP |
| 102056869 | May 2011 | IN |
| S5746925 | Mar 1982 | JP |
| H0549943 | Mar 1993 | JP |
| H06-142456 | May 1994 | JP |
| H07-096195 | Apr 1995 | JP |
| H08155303 | Jun 1996 | JP |
| H1133412 | Feb 1999 | JP |
| H11151440 | Jun 1999 | JP |
| 2000197822 | Jul 2000 | JP |
| 2000511107 | Aug 2000 | JP |
| 2000323164 | Nov 2000 | JP |
| 2002255537 | Sep 2002 | JP |
| 2002336704 | Nov 2002 | JP |
| 2004528158 | Sep 2004 | JP |
| 2005170903 | Jun 2005 | JP |
| 2005189586 | Jul 2005 | JP |
| 2005270734 | Oct 2005 | JP |
| 2005314208 | Nov 2005 | JP |
| 2006021994 | Jan 2006 | JP |
| 2007130525 | May 2007 | JP |
| 2007519799 | Jul 2007 | JP |
| 2008012382 | Jan 2008 | JP |
| 2008542177 | Nov 2008 | JP |
| 2009505830 | Feb 2009 | JP |
| 2009255014 | Nov 2009 | JP |
| 2010501496 | Jan 2010 | JP |
| 2010099638 | May 2010 | JP |
| 2010527769 | Aug 2010 | JP |
| 2011517439 | Jun 2011 | JP |
| 9745197 | Dec 1997 | WO |
| 9745387 | Dec 1997 | WO |
| 2005083014 | Sep 2005 | WO |
| 2007000847 | Jan 2007 | WO |
| 2007023558 | Mar 2007 | WO |
| 2009096548 | Aug 2009 | WO |
| 2010097108 | Sep 2010 | WO |
| 2010097224 | Sep 2010 | WO |
| 2011065194 | Jun 2011 | WO |
| Entry |
|---|
| Narayanan et al., “Structural, morphological and catalytic investigations on hierarchical ZSM-5 zeolite hexagonal cubes by surfactant assisted hydrothermal method”, Powder Technology, 274, (2015), 338-348. |
| Pernicone et al., “Catalyst Activation By Reduction”, Pure & Appl. Chem. , vol. 50, 1978, 1169-1191. |
| Liu et al. “Cobalt nanoparticles imbedded into zeolite crystals: A tailor-made catlayst for one-step synthesis of gasoline from syngas”, Internatonal Journal of Hydrogen Energy 41, (2016), 21965-21978. |
| Decision of Rejection for Chinese Patent Application No. 201880035017.7 dated Aug. 1, 2023, pp. all. |
| Decision of Rejection for Chinese Patent Application No. 201880035525.5 dated Jun. 13, 2023, pp. all. |
| Notification of the Third Office Action for Chinese Patent Application No. 201880035210.0 dated Jun. 15, 2023, pp. all. |
| Communication pursuant to Article 94(3) EPC for European Patent Application No. 18808807.4 dated Jul. 11, 2023, pp. all. |
| Communication pursuant to Article 94(3) EPC for European Patent Application No. 18809577.2, dated Jul. 10, 2023, pp. all. |
| Decision of Rejection for Chinese Patent Application No. 201880035360.1 dated Jun. 26, 2023, pp. all. |
| Decision of Rejection for Chinese Patent Application No. 201880036313.9 dated Jun. 27, 2023, pp. all. |
| Decision of Rejection for Chinese Patent Application No. 201880035173.3 dated Sep. 1, 2023, pp. all. |
| Narayanan, Subramanian, et al., “Structural, morphological and catalytic investigations on hierarchical ZSM-5 zeolite hexagonal cubes by surfactant assisted hydrothermal method”, Power Technology 274, 2015, pp. 338-348. |
| Reconsideration Report by Examiner before Appeal for Japanese Patent Application No. 2019-521318 dated Jul. 21, 2023, pp. all. |
| Decision of Rejection for Chinese Patent Application No. 201880035803.7 dated Aug. 10, 2023, pp. all. |
| Decision of Rejection for Chinese Patent Application No. 201880036312.4 dated Aug. 10, 2023, pp.all. |
| Decision of Rejection for the Chinese Patent Application No. 201880035026.6 dated Aug. 4, 2023, pp. all. |
| Extended European Search Report for EP Application No. 18809886.7, dated Jan. 29, 2021, pp. all. |
| [English Translation] First Office Action dated Apr. 20, 2022 for Chinese Patent Application No. 201880035803.7, pp. all. |
| [English Translation] First Office Action dated Jul. 11, 2022 for Chinese Patent Application No. 201880036382.X, pp. all. |
| [English Translation] First Office Action dated Jul. 13, 2022 for Chinese Patent Application No. 201880035026.6, pp. all. |
| [English Translation] First Office Action dated Jul. 5, 2022 for Chinese Patent Application No. 201880035017.7, pp. all. |
| [English Translation] First Office Action dated Jun. 29, 2022 for Chinese Patent Application No. 201880036388.7, pp. all. |
| [English Translation] First Office Action dated May 16, 2022 for Chinese Patent Application No. 201880036071.3, pp. all. |
| [English Translation] First Office Action dated May 5, 2022 for Chinese Patent Application No. 201880036312.4, pp. all. |
| [English Translation] First Office Action dated May 7, 2022 for Chinese Patent Application No. 201880035210.0, pp. all. |
| [English Translation] First Office Action dated on Jun. 27, 2022 for Chinese Patent Application No. 201880035525.5, pp. all. |
| [English Translation] First Office Action mailed on Aug. 3, 2022 for Chinese Patent Application No. 201880035569.8, bp. all. |
| [English Translation] First Office Action mailed on Aug. 3, 2022 for Chinese Patent Application No. 201880036313.9, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. 2019-521322 dated Apr. 4, 2023, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. 2019-521325 dated Apr. 4, 2023, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. 2019-521325 mailed on Sep. 27, 2022, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. 2019-521331 dated Apr. 4, 2023, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. 2019-521334, mailed on Sep. 27, 2022, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. 2019-521335, mailed Sep. 27, 2022, pp. all. |
| [English Translation] Notice of Reasons for Refusal for Japanese Patent Application No. JP-2019-521335 dated Apr. 4, 2023, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed Mar. 22, 2023 in JP Application No. 2019-521324; pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Aug. 16, 2022 for Japanese Patent Application No. 2019-521324, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Aug. 3, 2022 for Japanese Patent Application No. 2019-521322, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Aug. 3, 2022 for Japanese Patent Application No. 2019-521331, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Feb. 7, 2022 for Japanese Patent Application No. 2019-521334, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Feb. 7, 2022 for Japanese Patent Application No. 2019-521335, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Feb. 7, 2022 for Japanese Patent Application No. JP2019-521325, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Jun. 28, 2022 for Japanese Patent Application No. 2019-521318, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Jun. 28, 2022 for Japanese Patent Application No. 2019-521319, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Jun. 28, 2022 for Japanese Patent Application No. 2019-521320, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Jun. 28, 2022 for Japanese Patent Application No. 2019-521321, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Jun. 6, 2022 for Japanese Patent Application No. 2019-521326, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Mar. 16, 2022 for Japanese Patent Application No. 2019-521322, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Mar. 16, 2022 for Japanese Patent Application No. 2019-521331, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Mar. 28, 2022 for Japanese Patent Application No. 2019-521324, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Sep. 27, 2022 for Japanese Patent Application No. 2019-521325, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Sep. 27, 2022 for Japanese Patent Application No. 2019-521334, pp. all. |
| [English Translation] Notice of Reasons for Refusal mailed on Sep. 27, 2022 for Japanese Patent Application No. 2019-521335, pp. all. |
| [English Translation] Saudi Arabian Office Action dated Jan. 27, 2022 for Saudi Arabian Patent Application No. 519410663, pp. all. |
| [English Translation] Second Office Action dated Dec. 23, 2022 in CN Application No. 201880035210.0; pp. all. |
| [English Translation] Second Office Action dated Jan. 5, 2023 in CN Application No. 201880035525.5; pp. all. |
| [English Translation] Second Office Action mailed Feb. 18, 2023 in CN Application No. 201880035173.3; pp. all. |
| [English Translation] Second Office Action mailed Feb. 24, 2023 in CN Application No. 201880035569.8; pp. all. |
| [English Translation] Second Office Action mailed Jan. 18, 2023 in CN Application No. 201880036313.9; pp. all. |
| [English Translation] The First Office Action dated Jul. 20, 2022 for Chinese Patent Application No. 201880035173.3, pp. all. |
| [English Translation] The First Office Action dated Jul. 20, 2022 for Chinese Patent Application No. 201880035360.1, pp. all. |
| [English Translation] Third Office Action mailed Mar. 8, 2023 for CN Application No. 201880035803.7; pp. all. |
| [English Translation] Third Office Action mailed Mar. 8, 2023 in CN Application No. 201880036312.4; pp. all. |
| [Now published as 20200114336 (A1)] U.S. Appl. No. 16/698,567, filed Nov. 27, 2019, pp. all. |
| [Published as US-2020-0114341-A1] U.S. Appl. No. 16/698,679 titled Functional Structural Body And Method For Making Functional Structural Body' filed Jan. 2, 2020, pp. all. |
| [Published as US-2020-0115248-A1] U.S. Appl. No. 16/698,636 titled “Functional Structural Body And Method For Making Functional Structural Body” filed Jan. 2, 2020, pp. all. |
| Number | Date | Country | |
|---|---|---|---|
| 20230330646 A1 | Oct 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16698670 | Nov 2019 | US |
| Child | 18303034 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/JP2018/021079 | May 2018 | WO |
| Child | 16698670 | US |
